Correlation Between Chunghwa Telecom and Apex Biotechnology
Can any of the company-specific risk be diversified away by investing in both Chunghwa Telecom and Apex Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chunghwa Telecom and Apex Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Chunghwa Telecom Co and Apex Biotechnology Corp, you can compare the effects of market volatilities on Chunghwa Telecom and Apex Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chunghwa Telecom with a short position of Apex Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chunghwa Telecom and Apex Biotechnology.
Diversification Opportunities for Chunghwa Telecom and Apex Biotechnology
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Chunghwa and Apex is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Chunghwa Telecom Co and Apex Biotechnology Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apex Biotechnology Corp and Chunghwa Telecom is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chunghwa Telecom Co are associated (or correlated) with Apex Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apex Biotechnology Corp has no effect on the direction of Chunghwa Telecom i.e., Chunghwa Telecom and Apex Biotechnology go up and down completely randomly.
Pair Corralation between Chunghwa Telecom and Apex Biotechnology
Assuming the 90 days trading horizon Chunghwa Telecom is expected to generate 2.54 times less return on investment than Apex Biotechnology. But when comparing it to its historical volatility, Chunghwa Telecom Co is 2.31 times less risky than Apex Biotechnology. It trades about 0.19 of its potential returns per unit of risk. Apex Biotechnology Corp is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest 2,980 in Apex Biotechnology Corp on December 30, 2024 and sell it today you would earn a total of 375.00 from holding Apex Biotechnology Corp or generate 12.58% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Chunghwa Telecom Co vs. Apex Biotechnology Corp
Performance |
Timeline |
Chunghwa Telecom |
Apex Biotechnology Corp |
Chunghwa Telecom and Apex Biotechnology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Chunghwa Telecom and Apex Biotechnology
The main advantage of trading using opposite Chunghwa Telecom and Apex Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chunghwa Telecom position performs unexpectedly, Apex Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apex Biotechnology will offset losses from the drop in Apex Biotechnology's long position.Chunghwa Telecom vs. Taiwan Mobile Co | Chunghwa Telecom vs. China Steel Corp | Chunghwa Telecom vs. Formosa Plastics Corp | Chunghwa Telecom vs. Cathay Financial Holding |
Apex Biotechnology vs. Grape King Bio | Apex Biotechnology vs. Standard Chemical Pharmaceutical | Apex Biotechnology vs. China Steel Chemical | Apex Biotechnology vs. Sinphar Pharmaceutical Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |